Background: Data analysis plays a pivotal role in transforming raw data into findings that are transparent, reproducible, and clinically meaningful and useful, which is critical when analyzing insulin-related data for diabetes studies. Failing to do so will make subsequent analysis of insulin data irrelevant due to inaccuracies. Objective: Describe the end-to-end pre-processing steps used for assessing the T1DEXI dataset and why these steps are necessary before moving to data analysis. Methods: Standardize and harmonize the raw datasets, including comparing devices and adjusting per-device pre-processing steps; mitigating gaps in data; accounting for extended insulin delivery that is articulated as single timestamp records as well as similarly accounting for suspension of insulin delivery, taking into account the periods of time in which insulin was or was not delivered. Results: Insulin-related data is transformed to uniform per-5-minute intervals and is able to be used for subsequent analysis and event-based interpretation. Conclusions: As it relates to insulin delivery, pre-processing should be used to make sure that insulin delivery is uniformly analyzed down to 5-minute intervals so that all insulin delivery event types, whether those be manual up-front boluses; basal or temporary basal rates; and extended bolus events (such as square or dual/square wave boluses) and suspend events are correctly documented as a timeseries such that subsequent analysis will be accurate based on the duration of insulin activity.